Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets

v3.7.0.1
Interim Consolidated Balance Sheets - USD ($)
Feb. 28, 2017
Nov. 30, 2016
CURRENT    
Cash and cash equivalent $ 1,149,900 $ 192,826
Accounts Receivable 7,539 32,534
Inventory 45,016 7,323
Prepaid expenses and other receivables 74,138 50,037
Total Current Assets 1,276,593 282,720
Deferred financing costs 0 36,874
Property and Equipment 60,227 50,496
TOTAL ASSETS 1,336,820 370,090
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 300,691 245,911
Unsecured Convertible Debentures, net of deferred financing costs of $nil and $35,769, respectively 140,058 1,117,771
Total Current Liabilities 440,749 1,363,682
Long term secured Convertible Debentures, net of deferred financing costs of $93,646 and $nil, respectively 1,615,201 0
Derivative Financial Instruments 467,671 0
Total Liabilities 2,523,621 1,363,682
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2015 - nil). 0 0
Common stock, $0.001 par value 100,000,000 shares authorized (2016: 100,000,000), 55,693,907 issued and outstanding (2016: 54,615,642) 55,694 55,105
Additional Paid-In Capital 27,356,685 27,307,274
Deficiency (28,563,975) (28,298,613)
Accumulated other comprehensive loss (35,205) (57,358)
Total Stockholders' Deficiency (1,186,801) (993,592)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 1,336,820 $ 370,090